Estrogen regulates forkhead transcription factor 2 to promote apoptosis of human ovarian granulosa-like tumor cells

The Journal of Steroid Biochemistry and Molecular Biology
Jun WuDi Wang

Abstract

Granulosa cell tumors of the ovary (GCTs) are the predominant form of ovarian stromal tumors and can lead to abnormally secreted estrogen hormones. Studies have reported that forkhead transcription factor 2 (FOXL2) inhibits estrogen synthesis and its gene mutation can lead to GCTs. We unexpected found that estrogen also regulates the expression level of FOXL2. High-dose estrogen increased the expression of FOXL2 in ovarian-like granulosa (KGN) cells at both the mRNA and protein levels. However, no research has reported on the molecular regulatory mechanism and function between estrogen and FOXL2 in the development of GCTs. In this research, FOXL2 was highly expressed in KGN cells and ovarian stromal tumor tissues. Deletion of FOXL2 increased the estrogen secretion in KGN cells. In turn, high-dose estrogen increased the FOXL2 expression levels. FOXL2 was phosphorylated by GPR30 (G protein coupled receptor)-Protein kinase C (PKC) signaling pathway upon estrogen stimulation. Estrogen inhibited cell migration and proliferation, while promoting cell apoptosis. Deletion of FOXL2 inhibited the influence of estrogen on cell proliferation, migration, and apoptosis. Results suggest that estrogen via regulating FOXL2 suppresses cell proli...Continue Reading

References

Oct 12, 1973·Science·E V Jensen, E R DeSombre
Apr 11, 1997·European Journal of Pharmacology·A E Eckly-MichelC Lugnier
Feb 22, 2001·Annual Review of Physiology·D M Stocco
Jul 19, 2001·The Journal of Biological Chemistry·J M HallK S Korach
Jul 5, 2003·Physiological Reviews·Ralf M LoselMartin Wehling
Dec 23, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Sacha J HowellAnthony Howell
Apr 2, 2004·Human Molecular Genetics·Manuela UdaGiuseppe Pilia
Dec 14, 2004·Journal of Molecular Endocrinology·Daniel BaronReiner A Veitia
Feb 12, 2005·Science·Chetana M RevankarEric R Prossnitz
Jun 10, 2005·Human Molecular Genetics·Chris OttolenghiDavid Schlessinger
Jul 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicoletta ColomboAlessandra Insinga
Oct 6, 2007·Endocrine Reviews·Stephen R Hammes, Ellis R Levin
Jun 13, 2008·Nature Protocols·Thomas D Schmittgen, Kenneth J Livak
Jun 12, 2009·The New England Journal of Medicine·Sohrab P ShahDavid G Huntsman
Nov 18, 2009·Fertility and Sterility·Ikuko K Bentsi-BarnesMargareta D Pisarska
Dec 17, 2009·Cell·N Henriette UhlenhautMathias Treier
Feb 24, 2011·The Journal of Biological Chemistry·Qian WuPhilip W Shaul
Jan 14, 2012·Endocrine Reviews·Stacey Jamieson, Peter J Fuller
Oct 3, 2012·PloS One·Roseanne RosarioAndrew N Shelling
Dec 18, 2013·Gynecologic Oncology·Roseanne RosarioAndrew N Shelling
Apr 8, 2015·The Journal of Biological Chemistry·Quang-Kim TranJennifer Giles
Nov 5, 2016·The Journal of Molecular Diagnostics : JMD·Anniina FärkkiläDavid G Huntsman
Dec 14, 2017·International Journal of Molecular Sciences·Wiesława KrancBartosz Kempisty

❮ Previous
Next ❯

Citations

Apr 17, 2020·Frontiers in Endocrinology·Jing Luo, Dongmin Liu
Aug 28, 2020·Journal of Biochemical and Molecular Toxicology·Xiaoyu LvDi Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis